Associate Alison Siedor discuss recent activity around the 2010 Biologics Price Competition and Innovation Act (BPCIA) and how it set up an abbreviated biosimilar regulatory pathway and a unique litigation framework for resolving related patent disputes.
Read the full article.
Read the full article.